Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of PKC inhibitors and therapaeutic agents for treating cancers

Combinations of PKC inhibitors and therapaeutic agents for treating cancers

US Patent 5821072 · Granted Oct 13, 1998

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of preventing cancer metastasis2024
Methods and compositions for treating cancer using peptide nucleic acid-based ag2022
Methods and compositions for treating cancer using peptide nucleic acid-based ag2020
Reduced risk tobacco products and methods of making same2020
DDX43 as a biomarker of resistance to MEK1/2 inhibitors2019
Methods and compositions for treating cancer using peptide nucleic acid-based ag2018
Companion diagnostic for CDK4 inhibitors2018
Reduced risk tobacco products and methods of making same2016
Global gene expression analysis of human bronchial epithelial cells exposed to c2010
Approaches to identify less harmful tobacco and tobacco products2010
Combination of bryostatin and paclitaxel for treating cancer2006
Combination of bryostatin and paclitaxel for treating cancer2006